Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new site revision tag Revision: v3.5.4 was added, and the previous Revision: v3.5.3 was removed.
    Difference
    0.1%
    Check dated 2026-05-17T08:32:01.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan was removed from the study locations and Taoyuan, Taiwan was added, clarifying the site in Taoyuan. This updates the geographic listing of trial sites.
    Difference
    0.1%
    Check dated 2026-05-03T01:38:55.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor administrative release for the ClinicalTrials.gov site.
    Difference
    0.1%
    Check dated 2026-04-25T18:40:49.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:32:58.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Publication added under Publications: Lancet Oncology 2024 article on pathological response following neoadjuvant immune checkpoint inhibitors in hepatocellular carcinoma (HCC).
    Difference
    0.1%
    Check dated 2026-03-28T03:19:19.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a condition term and a Genetics and Rare Diseases Information Center resource. The site footer revision updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-21T00:49:12.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.